Tuberculosis

Low-Level Delamanid and Bedaquiline Resistance in Extremely Drug-Resistant TB

By

Sweta Gupta Editor

Researchers reported a case of drug resistance against 2 recently approved antitubercular medications: delamanid and bedaquiline.

Rifapentine Plus Isoniazid Noninferior to Isoniazid in HIV-Related TB

By

Bradley van Paridon

For prevention of TB in people with HIV, a single month regimen of rifapentine plus isoniazid was noninferior to 9 months of isoniazid alone.

CDC: Tuberculosis Incidence Declined in United States in 2017

Number of tuberculosis cases and incidence decreased globally, but more progress is needed to meet targets.

QuantiFERON-TB Gold-Plus Performance in Children With Confirmed Tuberculosis

By

Pulmonology Advisor Contributing Writer

The new interferon-gamma release assay QuantiFERON-TB Gold Plus had good sensitivity in children with pulmonary tuberculosis.

Building a Tuberculosis-Free World

By

Zahra Masoud

The first-ever UN High-Level Meeting on tuberculosis, in September 2018, resolved that ending the disease is a global priority.

Moxifloxacin Not Superior to Ethambutol for Recurrent Tuberculosis

By

Pulmonology Advisor Contributing Writer

Replacing ethambutol with moxifloxacin has not shown efficacy in tuberculosis treatment success in an 8-week trial.

Short Regimen Noninferior for Rifampin-Resistant Tuberculosis

A short regimen for rifapin-resistant tuberculosis was noninferior to 20-month regimen.

Diagnosing Chronic Pulmonary Aspergillosis in Treated Pulmonary TB

By

Sweta Gupta Editor

Chronic pulmonary aspergillosis complicates treated pulmonary tuberculosis frequently.